A detailed history of Invesco Ltd. transactions in Ardelyx, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 114,431 shares of ARDX stock, worth $651,112. This represents 0.0% of its overall portfolio holdings.

Number of Shares
114,431
Previous 112,570 1.65%
Holding current value
$651,112
Previous $834,000 5.52%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$5.28 - $7.57 $9,826 - $14,087
1,861 Added 1.65%
114,431 $788,000
Q2 2024

Aug 13, 2024

SELL
$5.89 - $9.31 $16,050 - $25,369
-2,725 Reduced 2.36%
112,570 $834,000
Q1 2024

May 14, 2024

SELL
$6.05 - $9.74 $13.4 Million - $21.6 Million
-2,217,832 Reduced 95.06%
115,295 $841,000
Q4 2023

Feb 12, 2024

BUY
$3.29 - $6.64 $3.19 Million - $6.44 Million
970,148 Added 71.18%
2,333,127 $14.5 Million
Q3 2023

Nov 13, 2023

BUY
$3.3 - $4.83 $4.11 Million - $6.01 Million
1,244,734 Added 1052.67%
1,362,979 $5.56 Million
Q2 2023

Aug 11, 2023

SELL
$3.23 - $4.95 $3.28 Million - $5.02 Million
-1,014,059 Reduced 89.56%
118,245 $400,000
Q1 2023

May 12, 2023

BUY
$2.68 - $4.79 $2.99 Million - $5.34 Million
1,115,133 Added 6494.28%
1,132,304 $5.42 Million
Q4 2022

Feb 13, 2023

BUY
$1.22 - $2.85 $20,948 - $48,937
17,171 New
17,171 $48,000
Q2 2022

Aug 15, 2022

SELL
$0.51 - $1.17 $15,250 - $34,985
-29,902 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$0.65 - $1.18 $186 - $338
-287 Reduced 0.95%
29,902 $32,000
Q4 2021

Feb 14, 2022

SELL
$0.86 - $1.7 $7,392 - $14,613
-8,596 Reduced 22.16%
30,189 $33,000
Q3 2021

Nov 15, 2021

BUY
$1.27 - $8.17 $8,004 - $51,495
6,303 Added 19.4%
38,785 $51,000
Q2 2021

Aug 17, 2021

BUY
$6.55 - $8.98 $102,854 - $141,012
15,703 Added 93.59%
32,482 $247,000
Q1 2021

May 17, 2021

BUY
$6.1 - $7.69 $21,813 - $27,499
3,576 Added 27.08%
16,779 $111,000
Q4 2020

Feb 16, 2021

BUY
$5.05 - $7.1 $66,675 - $93,741
13,203 New
13,203 $86,000
Q2 2020

Aug 14, 2020

SELL
$5.37 - $8.11 $587,907 - $887,882
-109,480 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$4.35 - $8.79 $338,364 - $683,730
-77,785 Reduced 41.54%
109,480 $622,000
Q4 2019

Feb 14, 2020

BUY
$4.23 - $8.29 $792,130 - $1.55 Million
187,265 New
187,265 $1.41 Million
Q1 2019

May 15, 2019

SELL
$1.88 - $3.35 $21,721 - $38,705
-11,554 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$1.66 - $4.16 $19,179 - $48,064
11,554 New
11,554 $21,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $880M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.